# CURB2 (NCT06686771)

> Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06686771
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Canadian Cancer Trials Group
- Conditions: Non-small Cell Lung Cancer
- Interventions: SBRT; First or second-line standard of care therapy
- Enrollment: 320
- Primary outcome: Progression-free survival
- Primary outcome: Overall survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 24
- YouTube: 5
- Podcasts: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=curb2-nct06686771

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06686771", "email": "<work email>"}; the inbox owner confirms by the emailed link.